Since its initial approval in 1989 by the US Food and Drug Administration for the treatment of
blepharospasm and other facial spasms, botulinum toxin (BoNT) has evolved into a …

Background Essential tremor is one of the most prevalent movement disorders. Many
treatments for essential tremor have been reported in clinical practice, but it is uncertain …

Deep brain stimulation (DBS) is an approved therapy for the treatment of medically refractory
and severe movement disorders. However, most existing neurostimulators can only apply …

Offering a state-of-the-art, authoritative summary of the most relevant scientific and clinical
advances in the field, Principles and Practice of Movement Disorders provides the expert …

Essential tremor is a common movement disorder. Tremor severity and handicap vary
widely, but most patients with essential tremor do not receive a diagnosis and hence are …

Essential tremor is one of the most common movement disorders in adults and can affect
both children and adults. An updated consensus statement in 2018 redefined essential …

Botulinum toxin, the most potent biological toxin, has become a powerful therapeutic tool for
a growing number of clinical applications. This review draws attention to new findings about …

Objective: To perform an evidence-based review of the safety and efficacy of botulinum
neurotoxin (BoNT) in the treatment of movement disorders. Methods: A literature search was …

Background: Essential tremor (ET) is one of the most common tremor disorders in adults and
is characterized by kinetic and postural tremor. To develop this practice parameter, the …

Botulinum neurotoxin (BoNT) can be injected to achieve therapeutic benefit across a large
range of clinical conditions. To assess the efficacy and safety of BoNT injections for the …